Steve D. Wilton

Murdoch University — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

53h-index13.2kcitations463works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(206), RNA Research and Splicing(130), RNA Interference and Gene Delivery(81), Neurogenetic and Muscular Disorders Research(72), RNA modifications and cancer(47)

Publications462 total

Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
Experimental Biology and Medicine·2025Open Access
Characterization of severe COL6-related dystrophy due to the recurrent variant <i>COL6A1</i> c.930+189C&amp;gt;T
Brain·2025· 1 citedOpen Access
Discovery of Novel APOC3 Isoforms in Hepatic and Intestinal Cell Models Using Long-Read RNA Sequencing
Genes·2025Open Access
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson’s disease
npj Parkinson s Disease·2025· 5 citedOpen Access
Skipping of Duplicated Dystrophin Exons: In Vitro Induction and Assessment
Methods in molecular biology·2025
10P Characterization of the severe phenotype of COL6-related dystrophy due to the recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C&gt;T
Neuromuscular Disorders·2024
THE RELATIONSHIP BETWEEN FRAILTY AND POSTOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Canadian Journal of Cardiology·2024Open Access
PREDICTORS OF EARLY RHYTHM CONTROL AND ASSOCIATED CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: A POPULATION BASED ANALYSIS
Canadian Journal of Cardiology·2024Open Access
Antisense oligonucleotides and their applications in rare neurological diseases
Frontiers in Neuroscience·2024· 16 citedOpen Access
Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers–Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?
International Journal of Molecular Sciences·2024Open Access
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Risk factors associated with surgical site infection following orthopaedic surgery in South Africa and Sub-Saharan Africa: a scoping review protocol
Journal of Wound Care·2024
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions
Frontiers in Molecular Neuroscience·2024· 13 citedOpen Access
Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities
International Journal of Molecular Sciences·2024· 8 citedOpen Access
The recurrent deep intronic pseudoexon-inducing variant <i>COL6A1</i> c.930+189C&gt;T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy
2024· 1 citedOpen Access
Microalgae as a source of bioavailable heme
Algal Research·2023· 7 citedOpen Access
Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations
Scientific Reports·2023Open Access
Induced alternative splicing: opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations
Research Square (Research Square)·2023Open Access
Supplementary Figures 9 - 10 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
2023Open Access
Supplementary Methods and Figure Legend from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
2023Open Access
page 1 of 24Next →

Frequent Co-authors

Sue Fletcher(23), Kaite Honeyman(7), P. Anthony Akkari(6), Nigel G. Laing(6), Jennifer E. Morgan(5), Francesco Muntoni(5), Graham McClorey(5), Patrick L. Iversen(5), Abbie Fall(5), Penny L Harding(5), George Dickson(4), Ryszard Kole(4), S.M. Dorosz(4), Hong M. Moulton(4), Frank Mastaglia(4), Virginia Arechavala‐Gomeza(3), Terence A. Partridge(3), Qi Long Lu(3), Christopher J. Mann(3), Glenn E. Morris(3)